Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Nolato AB (NLTBF) reports a 4% currency-adjusted revenue growth, driven by Medical Solutions, despite challenges from rising raw material costs.
In the midst of a dynamic global market landscape, small-cap stocks have faced challenges as large-cap counterparts outpaced them amid rising energy prices and hawkish signals from central banks. Despite these hurdles, the Russell 2000 Index still managed to post a year-to-date gain of 13.33%, highlighting potential opportunities for investors seeking value in smaller companies. In this context, identifying promising small caps involves looking for those with strong fundamentals and insider...
Despite currency headwinds, Nolato AB (NLTBF) reports solid growth in Medical Solutions and improved margins, while navigating cost pressures and market volatility.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.